The prevalence of epstein-barr virus infection in different types and sites of lymphomas

Japanese Journal of Infectious Diseases

Volumn 63, Issue 2, 2010, Pages 132-135

  Zhang, Yang ^a   Peng, Jinyun ^a   Tang, Yunlian ^a   He, Jie ^a   Peng, Juan ^a   Zhao, Qiang ^a   He, Rongfang ^a   Xie, Xiaoli ^a   Peng, Xueqin ^a   Gan, Runliang ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE;

ADULT; ARTICLE; B CELL LYMPHOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; LYMPH NODE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NASOPHARYNX; NK T CELL LYMPHOMA; NONHODGKIN LYMPHOMA; NOSE CAVITY; STOMACH; STOMACH LYMPHOMA; TUMOR CELL; TUMOR LOCALIZATION; VIRUS DETECTION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU HYBRIDIZATION; LYMPH NODES; LYMPHOMA; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NOSE NEOPLASMS; PREVALENCE; RNA, VIRAL; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 77950663047     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Maeda, E., Akahane, M., Kiryu, S., et al. (2009): Spectrum of Epstein-Barr virus-related diseases: a pictorial review. Jpn. J. Radiol., 27, 4-19.
2. Novak, A.J., Slager, S.L., Fredericksen, Z.S., et al. (2009): Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma. Cancer Res., 69, 4217-4224.
3. Thorley-Lawson, D.A. and Gross, A. (2004): Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N. Engl. J. Med., 350, 1328-1337.
4. Baumforth, K.R., Young, L.S., Flavell, K.J., et al. (1999): The Epstein-Barr virus and its association with human cancers. Mol. Pathol., 52, 307-322.
5. Carbone, A., Gloghini, A. and Dotti, G. (2008): EBV-associated lymphoproliferative disorders: classification and treatment. Oncologist, 13, 577-585.
6. Gan, R., Yin, Z., Liu, T., et al. (2003): Cyclosporine A effectively inhibits graft-versus-host disease during development of Epstein-Barr virus-infected human B cell lymphoma in SCID mouse. Cancer Sci., 94, 796-801.
7. Gan, R.L., Yin, Z.H., Liu, T.F., et al. (2003): Molecular pathological characteristics of human B-cell lymphomas induced by Epstein-Barr virus. Acta Biochim. Biophys. Sin. (Shanghai), 35, 925-929 (in Chinese).
8. Gan, R.L., Lan, K., Yin, Z.H., et al. (2005): Construction of hu-PBL/ SCID chimeras and development of EBV-related lymphomas. Chin. Med. Sci. J., 20, 16-22.
9. Trimeche, M., Bonnet, C., Korbi, S., et al. (2007): Association between Epstein-Barr virus and Hodgkin's lymphoma in Belgium: a pathological and virological study. Leuk. Lymphoma, 48, 1323-1331.
10. Cho, E.Y., Kim, K.H., Kim, W.S., et al. (2008): The spectrum of Epstein-Barr virus-associated lymphoproliferative disease in Korea: incidence of disease entities by age groups. J. Korean Med. Sci., 23, 185-192.
11. Lee, J., Suh, C., Huh, J., et al. (2007): Effect of positive bone marrow EBV in situ hybridization in staging and survival of localized extranodal natural killer/T-cell lymphoma, nasal-type. Clin. Cancer Res., 13, 3250-3254.
12. Oyama, T., Yamamoto, K., Asano, N., et al. (2007): Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin. Cancer Res., 13, 5124-5132.
13. Gulley, M.L. and Tang, W. (2008): Laboratory assays for Epstein-Barr virus-related disease. J. Mol. Diagn., 10, 279-292.
14. Lones, M.A., Shintaku, I.P., Weiss, L.M., et al. (1997): Posttransplant lymphoproliferative disorder in liver allograft biopsies: a comparison of three methods for the demonstration of Epstein-Barr virus. Hum. Pathol., 28, 533-539.
15. Khan, G. (2009): Screening for Epstein-Barr virus in Hodgkin's lymphoma. Methods Mol. Biol., 511, 311-322.
16. Kuo, T.T., Shih, L.Y. and Tsang, N.M. (2004): Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities. Int. J. Surg. Pathol., 12, 375-387.
17. Xiang-Lan, M., Zu-Lan, S., Dan, H., et al. (2008): Skp2/p27 expression profile is correlated with Epstein-Barr virus status in extranodal nasal-type natural killer cell lymphoma. Transl. Res., 151, 303-308.
18. Lee, Y., Lee, K.W., Kim, J.H., et al. (2008): Epstein-Barr virus-positivity in tumor has no correlation with the clinical outcomes of patients with angioimmunoblastic T-cell lymphoma. Korean J. Intern. Med., 23, 30-36.
19. Gregory, C.D., Dive, C., Henderson, S., et al. (1991): Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature, 349, 612-614.
20. Gualco, G., Chioato, L., Van Den Berg, A., et al. (2009): Composite lymphoma: EBV-positive classic Hodgkin lymphoma and peripheral T-cell lymphoma: a case report. Appl. Immunohistochem. Mol. Morphol., 17, 72-76.
21. Novelli, M., Merlino, C., Ponti, R., et al. (2009): Epstein-Barr virus in cutaneous T-cell lymphomas: evaluation of the viral presence and significance in skin and peripheral blood. J. Invest. Dermatol., 129, 1556-1561.
22. Brauninger, A., Schmitz, R., Bechtel, D., et al. (2006): Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma. Int. J. Cancer, 118, 1853-1861.
23. Chang, K.C., Chen, P.C., Jones, D., et al. (2008): Changing patterns in the frequency of Hodgkin lymphoma subtypes and Epstein-Barr virus association in Taiwan. Cancer Sci., 99, 345-349.